UAE warns against counterfeit Botox batch, cites health risks

The Emirates Drug Establishment (EDE) has issued an urgent alert concerning a counterfeit batch of Botox Cosmetic for Injection 100 Units, identified by Batch Number C7048C4. The EDE confirmed that this batch number does not align with the records of the product's American manufacturer, AbbVie.

Further investigation revealed that the counterfeit product was not imported through any channels officially approved by the EDE. The establishment emphasized that the use of such unverified products poses a significant risk to public health. These counterfeit items do not meet approved specifications, and their administration could lead to harmful health reactions or unforeseen complications.

Healthcare providers, pharmacies, and medical facilities are strongly advised to meticulously check the authenticity of all medical products before use or distribution. They must immediately stop using or distributing any products bearing the specified counterfeit batch number. The EDE also stressed the importance of consulting a doctor or pharmacist if any unusual symptoms arise after use and urged the public to report any suspicious products or irregular activities related to this batch.